Eloxx Pharmaceuticals

$4.13
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.05 (-1.20%) Today

$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ELOX and other stocks, options, and ETFs commission-free!

About ELOX

Eloxx Pharmaceuticals, Inc. engages in the development of novel ribonucleic acid modulating drug candidates. The firm focuses on the the formulation of medicines to treat rare and ultra-rare premature stop codon diseases. It operates through the United States and Israel geographical segments. Its product includes ELX-02, a small molecule drug designed to restore production of full-length functional proteins which treats cystic fibrosis and cystinosis. The company was founded by Silvia Noiman on December 19, 2017 and is headquartered in Waltham, MA. The listed name for ELOX is Eloxx Pharmaceuticals, Inc. Common Stock.

CEO

Gregory C. Williams

Employees

Headquarters

Waltham, Massachusetts

Founded

2017

Market Cap

159.88M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

70.84K

High Today

$4.23

Low Today

$3.90

Open Price

$4.12

Volume

101.57K

52 Week High

$6.77

52 Week Low

$1.44

Collections

ELOX Earnings

-$0.40

-$0.27

-$0.13

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 4, After Hours